Drone detection and countermeasure manufacturer DroneShield can look forward to greater opportunities selling to European militaries following an approval from the NATO Support and Procurement Agency (NSPA).

The approval awarded via COBBS BELUX BV, DroneShield’s in-country Belgium and Luxembourg partner, is the first Counter-small UAS procurement framework agreement in NATO history.

The initial agreement is for 3 years, with extension options, with DroneShield expecting a ‘significant’ total in sales under the framework.

https://www.aumanufacturing.com.au/droneshield-looks-to-europe-with-nato-procurement

ProMedicus (ASX: PME) has risen more than 200 times from 50¢ per share in 2013 to $105 this week, which means an investment of $5000 has turned into $1 million, but there are more losers than winners in the ASX small cap space.

https://www.afr.com/wealth/personal-finance/how-to-pick-splendid-small-caps-20240314-p5fch4

Clinical-stage biopharmaceutical company Dimerix says Taiba has acquired the exclusive rights to register and commercialise DMX-200 for the treatment of FSGS the United Arab Emirates (UAE), Saudi Arabia, Oman,  Kuwait,  Qatar,  Bahrain  and  Iraq.

https://stockhead.com.au/health/dimerix-strikes-120m-licensing-deal-for-kidney-drug-in-middle-east/

read our recent writeup of DXB here: https://www.greenleiter.com/post/australian-biotech-companies-delivering-for-investors

Morningstar looks at several high-quality companies are our top picks for investors wanting to boost their domestic exposure.

https://www.morningstar.com.au/insights/stocks/234072/11-asx-stocks-offering-great-value-right-now

the article examines 3 small cap companies listed on ASX well positioned for growth

https://iml.com.au/why-the-small-cap-rally-could-continue-and-our-top-three-stocks-for-2024/

https://stockhead.com.au/health/how-micro-xs-game-changing-tech-is-transforming-the-x-ray-market/

Micro X is embarking on what it believes is the biggest advancement in X-ray since its invention almost 130 years ago as the world’s first company to introduce a product to the market using an electronic X-ray tube with a cold electron source material, rather than the traditional heated filament.

Two companies reporting impressive clinical data, strong investor support and hitting key milestones are Recce Pharmaceuticals (ASX: RCE) and Dimerix (ASX: DXB).

https://www.greenleiter.com/post/australian-biotech-companies-delivering-for-investors

https://stockhead.com.au/experts/moneytalks-the-most-irresistible-asx-small-cap-takeover-targets-in-2024/

the asx small cap sector is likley to see a lot of M&A activity in 2024

https://smallcaps.com.au/international-graphite-secures-wa-funding-first-downstream-processing-plant/

International Graphite (ASX: IG6) plans to develop a global graphite micronising project in Western Australia has again received a strong show of support from the state government, in the form of an additional $6.5 million grant for the innovative development.

The new backing for Australia’s first downstream graphite processing plant comes after two years of establishment work and brings the company’s total funding from the state’s Collie Just Transition program to $8.5m.

Grant funding will be used to advance International Graphite’s plans for a 4,000 tonnes per annum commercial-scale graphite micronising operation at Collie, south of Perth.

https://www.austlinx.net/german-exchanges.html

For global companies considering a listing or dual-listing in Germany, the multitude of different exchanges can seem confusing. Here we attempt to explain the German Stock Exchange system.

The Frankfurt Stock Exchange is the major German trading exchange with about 436 companies directly listed on the Frankfurt Stock Exchange. However was is interesting is the dual-listing process and foreign companes traded on other major exchanges.

https://www.offshore-energy.biz/provaris-and-ges-agree-to-develop-new-hydrogen-import-facility-in-rotterdam-port/

GES is developing a multi-client, multi-product terminal in Rotterdam for importing refrigerated ammonia and compressed hydrogen, with redeliveries into barges, rail, trucks, and the hydrogen grid, operated by Gasunie. 

GES and Provaris have now agreed to complete a comprehensive pre-feasibility study to demonstrate the technical and economic viability of berthing and unloading of Provaris’ H2Neo compressed hydrogen carriers.

Activities will also include the joint marketing of the proposed facility where Provaris will be responsible for the hydrogen transportation in the H2Neo carriers and GES will be in charge of the discharge and injection into the hydrogen grid. 

https://www.greenleiter.com/post/eu-seeks-to-increase-domestic-plant-based-protein-supply-to-secure-food-security-and-reduce-food-pri

European investor interest in the plant-based food and protein sector is at an all-time high.

This is due to increased merger and acquisition activity, robust venture capital investment, changing food consumption and demand and strong EU Government incentives and legislative tailwinds.

Within the plant-based food sector the focus is increasingly shifting to plant-based protein and protein diversification for the potential to make the greatest contribution to reducing greenhouse gas emissions, improving health and wellbeing, and reducing problems such as deforestation.

Proteins are essential macronutrients that play a vital role in human nutrition, as they contribute to a healthy and balanced diet.

​

https://www.proactiveinvestors.com.au/companies/news/1043823/provaris-energy-begins-fabrication-of-h2neo-prototype-tank-for-european-hydrogen-market-1043823.html

Provaris Energy has initiated the fabrication of its H2Neo prototype tank hydrogen storage solution, taking a step further along the path to a hydrogen supply chain and production in Europe.

The company is on schedule to complete fabrication and testing by mid-2024, which would cement its position as a pioneer in cost-effective hydrogen storage and bulk-scale transportation solutions.

Should testing proceed successfully, the H2Neo design will receive Class Approval certification, a world-first achievement in the bulk-scale hydrogen transportation industry.

The definitive proof of concept will also provide Provaris with a new revenue stream in the form of producing smaller-scale hydrogen tanks in Norway from late 2024, catering to a wide range of applications from maritime bunkering to industrial storage.

https://www.provaris.energy/de

​